Solid biosciences reports inducement grants under nasdaq listing rule 5635(c)(4)

Charlestown, mass., june 03, 2025 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced grants of 34,550 restricted stock units (“rsus”) to two newly hired employees.

NDAQ Ratings Summary

NDAQ Quant Ranking